SECOBARBITAL Latest Revision: February 15, 1999

Similar documents
BUFOTENINE Latest Revision: August 16, 2005

PHENCYCLIDINE Latest Revision: May 16, 2005

BENZYLPIPERAZINE Latest Revision: June 1, 2005

1-(2-METHOXYPHENYL)PIPERAZINE Latest revision: June 27, 2005

5-METHOXY- -METHYLTRYPTAMINE Latest revision: June 20, 2005

5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE Latest Revision: June 20, 2005

p-methoxyamphetamine Latest Revision: May 16, 2013

2,5-DIMETHOXY-4-IODOPHENETHYLAMINE Latest Revision: August 22, 2005

DEXTROMETHORPHAN Latest Revision: June 23, 2005

Marquis (210 ml): Add 10 ml of 40% formaldehyde solution to 200 ml of concentrated sulfuric acid.

COMPLEX HEROIN COMPARISON INVESTIGATION

This method describes the identification of the following prohibited colorants in cosmetic products:

IDENTIFICATION AND DETERMINATION OF HYDROQUINONE IN COSMETIC PRODUCTS 2 14/11/17 ACM 003 BY TLC AND HPLC

TERTIARY BUTYLHYDROQUINONE

IDENTIFICATION OF STEROIDS IN COSMETIC PRODUCTS BY TLC AND HPLC 1 02/12/2005 ACM 007 A. THIN LAYER CHROMATOGRAPHY (TLC)

Drug-Control Laws. CRIMINALISTICS An Introduction to Forensic Science, 9/E. PRENTICE HALL 2007 Pearson Education, Inc.

Introduction to Pharmaceutical Chemical Analysis

Chemistry 3200 High Performance Liquid Chromatography: Quantitative Determination of Headache Tablets

Egualen Sodium Granules

Determination of Caffeine by HPLC

1. GENERAL INFORMATION IUPAC

3-Fluoromethcathinone Latest Revision: March 29, 2013

7. Stability indicating analytical method development and validation of Ramipril and Amlodipine in capsule dosage form by HPLC.

Gas Chromatography. 1. Experiment Category: 2. Experiment Name: 3. Date and Issue number: 4. Instructor Name: 5. Institution: Ain Shams University

H 3 CO H 3 CO S CH 3

The Isosorbide Mononitrate Extended-Release Tablets Revision Bulletin supersedes the currently official monograph.

TEMPLATE FOR AN EXAMPLE STANDARD TEST METHOD

EFAVIRENZ Final text for addition to The International Pharmacopoeia

Apparatus Needed To Perform Procedure Including Preparation of Reagent:

Opiates in Urine by SAMHSA GC/MS

ADVANTAME (TENTATIVE)

ARTEMETHER AND LUMEFANTRINE TABLETS: Final text for addition to The International Pharmacopoeia (July 2008)

Technical Procedure for Concentration Determination of Methamphetamine in Liquids via HPLC

Revision Bulletin 27 Jan Feb 2017 Non-Botanical Dietary Supplements Compliance

Selective Formation of Benzo[c]cinnoline by Photocatalytic Reduction of 2,2 Dinitrobiphenyl with TiO 2 and UV light irradiation

Chapter 4: Verification of compendial methods

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text.

Ondansetron Hydrochloride Tablets

LUMEFANTRINUM LUMEFANTRINE

BRIEFING. Pharmacopeial Discussion Group Sign Off Document Attributes EP JP USP Definition Loss on drying Readily carbonizable substances

ARTEMETHER AND LUMEFANTRINE ORAL SUSPENSION:Final text for addition to The International Pharmacopoeia (November 2008)

SPECIFICATION & TEST PROCEDURE SODIUM SALICYLATE Technical. Molecular weight : Reference : In-house

Quantitation of Cocaine by Gas Chromatography-Flame Ionization Detection Utilizing Isopropylcocaine as a Structurally Related Internal Standard

Chromatography. Gas Chromatography

Dissolution Test 5 was validated using a Zodiac C18 brand of L1 column. The typical retention time for atorvastatin is about min.

637. Thiamethoxam. HPLC method

Determination of Elemental Sulfur in Explosives and. Explosive Residues by Gas Chromatography-Mass Spectrometry. Kimberly S.

Revision Bulletin 29 Dec Jan 2018 Non-Botanical Dietary Supplements Compliance

Barbiturate Differentiation by Chemical Microscopy

VALIDATION OF A UPLC METHOD FOR A BENZOCAINE, BUTAMBEN, AND TETRACAINE HYDROCHLORIDE TOPICAL SOLUTION

ADVANTAME. Not less than 97.0% and not more than 102.0% on the anhydrous basis. Sweetener, flavour enhancer

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph.

BRIEFING. (EXC: K. Moore.) RTS C Propylparaben C 10 H 12 O Benzoic acid, 4 hydroxy, propyl ester; Propyl p hydroxybenzoate [ ].

METHOD 8032A ACRYLAMIDE BY GAS CHROMATOGRAPHY

Anethole. Gas chromatograhpy determination of trans-anethole in Spirit srinks of viti-vinicultural origin

Place a collection tube beneath cartridge. 3 ml methylene chloride/isopropyl alcohol/ hydrochloric acid (60/40/1) Collect the eluant

NEVIRAPINE ORAL SUSPENSION Final text for addition to The International Pharmacopoeia (February 2009)

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB5009.

Chromatography & instrumentation in Organic Chemistry

IMPROVED CHROMATOGRAPHIC METHOD FOR DETERMINATION OF SODIUM DICLOFENAC IN INJECTABLE SOLUTION AND PREDICTION OF CHEMICAL STABILITY

USP 36 Official Monographs / Metformin carding the first 3 ml of filtrate. Transfer 25 ml of the Analysis

Technical Procedure for Preliminary Color Tests

DETERMINATION OF DRUG RELEASE DURING DISSOLUTION OF NICORANDIL IN TABLET DOSAGE FORM BY USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

Benzoylecgonine in Urine by SAMHSA GC/MS

INDIGOTINE. Disodium 3,3'-dioxo-[delta 2,2' -biindoline]-5,5'-disulfonate (principal component) (principal component)

Volatile organic compounds (VOCs):

Analysis of BTEX in Natural Water with SPME

GUACO FOR HOMOEOPATHIC PREPARATIONS GUACO FOR HOMOEOPATHIC PREPARATIONS

Thin Layer Chromatography

Technical Procedure for Extractions and Separations

GB Translated English of Chinese Standard: GB NATIONAL STANDARD OF THE

School of Chemistry UNIVERSITY OF KWAZULU-NATAL, WESTVILLE CAMPUS JUNE 2009 EXAMINATION CHEM340: INSTRUMENTAL ANALYSIS.

Quantitative determination of ethephon in soluble concentration (SL) by Ion chromatography

Sulfotepp impurities in Chlorpyrifos EC formulations

4-Methyldiethcathinone (4-MDEC)

CYCLOSERINE Final text for addition to The International Pharmacopoeia. (November 2008) CYCLOSERINUM CYCLOSERINE

DOXYCYCLINE HYCLATE Final text to replace published monograph in The International Pharmacopoeia (November 2007)

TECHNICAL BRODIFACOUM

1-(1,3-benzodioxol-5-yl)-2-(ethylamino)hexan-1-one

12 Nicarbazin Nicarbazin (4,4 -dinitro carbanilid (DNC) and 2-hydroxy-4,6-dimethyl pyrimidine (HDP))

2-[[2-(4-ethyl-2,5-dimethoxy-phenyl)ethylamino]methyl]phenol

4-methyl-1-phenyl-2-pyrrolidin-1-yl-pentan-1-one

ASPARTAME. Not less than 98% and not more than 102% on the dried basis. White, odourless, crystalline powder, having a strong sweet taste

Determination of Carbonyl Compounds In Water by Dinitrophenylhydrazine Derivatization and HPLC/UV*

Simultaneous Estimation of Residual Solvents (Isopropyl Alcohol and Dichloromethane) in Dosage Form by GC-HS-FID

Application Note. Gas Chromatography/Mass Spectrometry/Food Safety. Abstract. Authors

Chapter 5: Identification, Assay and Related Substances

Methyl 1-[(4-fluorophenyl)methyl]indazole-3-carboxylate

Additionally, minor editorial changes have been made to update the monograph to current USP style.

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB5009.

4023 Synthesis of cyclopentanone-2-carboxylic acid ethyl ester from adipic acid diethyl ester

Validated RP-HPLC Method for Estimation of Cefprozil in Tablet Dosage Form

31. Applications of the chromatographic methods in drug analysis

2-(ethylamino)-1-(4-methylphenyl)propan-1-one (base), (HCl)

Should you have any questions, please contact Mary P. Koleck, Ph.D., Scientific Liaison ( or

Fast Analysis of USP 467 Residual Solvents using the Agilent 7890A GC and Low Thermal Mass (LTM) System

Revision Bulletin Official April 1, 2014 Alprazolam 1

Practical Faster GC Applications with High-Efficiency GC Columns and Method Translation Software

HANDBOOK OF DRUG ANALYSIS

Analysis of USP Method <467> Residual Solvents on the Agilent 8890 GC System

Transcription:

SECOBARBITAL Latest Revision: February 15, 1999 1. SYNONYMS CFR: Secobarbital CAS #: Free acid: 76-73-3 Sodium salt: 309-43-3 Other Names: 5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6-(1H,3H,5H)-pyrimidinetrione 5-Allyl-5-(1-methylbutyl) barbituric acid Seconal Quinalbarbitone 2. CHEMICAL AND PHYSICAL DATA 2.1. CHEMICAL DATA Form Chemical Formula Molecular Weight Melting Point ( C) Free acid C 12 H 18 N 2 O 3 238.2 100 Sodium salt C 12 H 17 N 2 NaO 3 260.2 150-155 2.2. SOLUBILITY Form A C E H M W Free acid *** S FS *** FS VSS Sodium salt *** I I *** FS FS A = acetone, C = chloroform, E = ether, H = hexane, M = methanol and W = water, VS = very soluble, FS = freely soluble, S = soluble, PS = sparingly soluble, SS = slightly soluble, VSS = very slightly soluble and I = insoluble

Note: A saturated aqueous solution of the free acid has a ph about 5.6. A 10% aqueous solution of the sodium salt has a ph from 9.7 to 10.5. 3. SCREENING TECHNIQUES 3.1. COLOR TESTS REAGENT Dille-Koppanyi Zwikker's Mercurous nitrate COLOR PRODUCED Violet Violet Black 3.2. CRYSTAL TESTS REAGENT Wagenaar's CRYSTALS FORMED Large rosettes of fine needles 3.3. THIN-LAYER CHROMATOGRAPHY Visualization Mercurous nitrate spray Acidified potassium permanganate spray COMPOUND RELATIVE R 1 System TLC7 System TLC12 barbituric acid 0.0 0.0 phenobarbital 0.8 0.4 amobarbital 0.9 0.9 pentobarbital 0.9 1.0 secobarbital 1.0 1.0 thiobarbital 1.4 1.0

3.4. GAS CHROMATOGRAPHY All gas chromatographic methods should be performed on the free acid of the barbiturate only, due to the poor chromatography of the sodium salts. The run time may be shortened by using an isothermal run, if no late eluting components are present in the sample. Method SEC-GCS1 Instrument: Column: Carrier gas: Gas chromatograph operated in split mode with FID 5% phenyl/95% methyl silicone 12.5 m x 0.2 mm x 0.33 µm film thickness Helium at 0.5 ml/min Temperatures: Injector: 230 C Detector: 250 C Oven program: 1) 175 C initial temperature for 6.0 min 2) Ramp to 260 C at 30 C/min 3) Hold final temperature for 10.0 min Injection Parameters: Split Ratio = 50:1, 1 µl injected For the free acid, samples are to be dissolved in chloroform and filtered. For the sodium salt, samples are initially added to 0.5 N sulfuric acid followed by extraction into chloroform prior to filtering and injection. COMPOUND RRT COMPOUND RRT amphetamine 0.16 amobarbital 0.76 pentadecane 0.34 secobarbital 1.00 (7.02 min) ephedrine 0.36 caffeine 1.16 butabarbital 0.63 methaqualone 1.69 acetaminophen 0.66 codeine 1.97 3.5. HIGH PERFORMANCE LIQUID CHROMATOGRAPHY Method SEC-LCS1 Instrument: Column: High performance liquid chromatograph equipped with diode array 5µm ODS, 150mm x 3.2mm

Detector: Flow: UV, 220 nm 0.750 ml/min Injection Volume: 10.0 µl Mobile Phase: 59% H 2 O, 1% glacial acetic acid, 40% methanol, 0.02 M methanesulfonic acid, adjust ph to 3.5 with 0.1 N sodium hydroxide Samples are to be dissolved in methanol and filtered with a 0.45-micron filter. COMPOUND RRT COMPOUND RRT amphetamine does not elute butabarbital 0.50 acetaminophen 0.24 cocaine 0.59 codeine 0.27 quinine 0.65 caffeine 0.34 amobarbital 0.80 aspirin 0.34 pentobarbital 0.80 heroin 0.40 secobarbital 1.00 (6.38 min) phenobarbital 0.40 methaqualone 1.47 4. SEPARATION TECHNIQUES The free acid may be extracted using dry chloroform or ether, if no other similarly soluble compounds are present. Alternatively, solvent extraction is performed by first dissolving the sample in an alkaline solution and extracting with chloroform or ether, and discarding the chloroform or ether layer. The solution is then acidified and the free acid is extracted with chloroform. Evaporation of the chloroform results in a white powder. The sodium salt can be isolated by first placing the sample in 0.5 N sulfuric acid. After shaking, the converted free acid can be extracted into chloroform. 5. QUANTITATIVE PROCEDURES 5.1. GAS CHROMATOGRAPHY Method SEC-GCQ1 Internal Standard Stock Solution: 0.4 mg/ml docosane in chloroform.

Standard Solution Preparation: Accurately weigh and prepare a standard solution of secobarbital (free acid) at approximately 0.5 mg/ml using above internal standard stock solution. Sample Preparation: Accurately weigh an amount of sample into a volumetric flask and dilute with internal standard stock solution. If necessary, dilute the sample so the final concentration approximates the standard concentration. Instrument: Column: Carrier gas: Gas chromatograph operated in split mode with FID 5% phenyl/95% methyl silicone 12.5 m x 0.2 mm x 0.33 µm film thickness Helium at 1.0 ml/mi Temperatures: Injector: 250 C Detector: 260 C Oven program: 210 C isothermal Injection Parameters: Typical Retention Time: Linear Range: Split Ratio = 60:1, 1 µl injected Secobarbital: 1.28 min Docosane: 3.70 min 0.05-1.0 mg/ml Repeatability: RSD less than 1.2% Correlation Coefficient: 0.999 Accuracy: Error less than 5% COMPOUND RRT COMPOUND RRT dimethylsulfone 0.31 diphenhydramine 1.27 nicotinamide 0.45 lidocaine 1.32 amphetamine 0.46 phenobarbital 1.63 ephedrine 0.47 procaine 1.97 benzocaine 0.57 docosane 2.89 methamphetamine 0.59 methaqualone 2.98 ibuprofen 0.64 cocaine >4.0

acetaminophen 0.76 tetracaine >4.0 phenacetin 0.79 tetracosane >4.0 amobarbital 0.84 codeine >4.0 pentobarbital 0.89 morphine >4.0 secobarbital 1.00 (1.28 min) heroin >4.0 caffeine 1.17 quinine >4.0 5.2. HIGH PERFORMANCE LIQUID CHROMATOGRAPHY Method SEC-LCQ1 Standard Solution Preparation: Accurately weigh and prepare a standard solution of secobarbital (free acid or sodium salt) at approximately 0.6 mg/ml using methanol. Sample Preparation: Accurately weigh an amount of sample into a volumetric flask and dilute with methanol. If necessary, dilute the sample so the final concentration approximates the standard concentration. Filter sample with 0.45-micron filter. Instrument: Column: Detector: Flow: High performance liquid chromatograph equipped with diode array 5 µm ODS, 150mm x 3.2mm UV, 220 nm 0.750 ml/min Injection Volume: 10.0 µl Mobile Phase: Typical Retention Time: Linear Range: 59% H 2 O, 1% glacial acetic acid, 40% methanol, 0.02 M methanesulfonic acid, adjust ph to 3.5 with 0.1 N sodium hydroxide Secobarbital: 6.38 min 0.1-1.0 mg/ml Repeatability: RSD less than 1.2% Correlation Coefficient: 0.9999 Accuracy: Error less than 5%

6. QUALITATIVE DATA 6.1. INFRARED SPECTROSCOPY (FT-IR) An additional difficulty in comparing the IR spectra of secobarbital arises from the existence of different crystalline forms or polymorphs, which generate differences in spectra. To overcome this difficulty, both sample and standard should be subjected to the same preparations. See spectra on the following pages for FT-IR, Mass Spectrometry, Nuclear Magnetic Resonance, and Vapor Phase IR. 7. REFERENCES Budavari, S., The Merck Index, 12 th Edition, Merck and Co., Inc., 1996, p. 1447. Clarke, E.G.C., Isolation and Identification of Drugs, 2nd Edition, The Pharmaceutical Press, 1986. Fulton, C.L., Modern Microcrystal Tests for Drugs, Wiley - Interscience, 1969. Horwitz, William, Ed., Official Methods of Analysis of the Association of Official Analytical Chemists, 12th ed., Association of Official Analytical Chemists, 1975. Saferstein, Richard, Ph.D., Forensic Science Handbook, Volume II, Prentice Hall, 1988. 8. ADDITIONAL RESOURCES Forendex Wikipedia